1. Some problems and errors in cytogenetic biodosimetry
   Irma Mosse et al, 2017, Biotechnology & Biotechnological Equipment CrossRef
2. Macrolides for Cancer
   Masahiro Shinoda, 2024, Macrolides as Immunomodulatory Agents CrossRef
3. Small-Molecule Regulators of Autophagy as Potential Anti-cancer Therapy
   Qing Li et al, 2016, Targeting Autophagy in Cancer Therapy CrossRef
4. Clarithromycin in rheumatoid arthritis: the addition to methotrexate and low-dose methylprednisolone induces a significant additive value—a 24-month single-blind pilot study
   Gianantonio Saviola et al, 2013, Rheumatology International CrossRef
5. Identification of a Five-Gene Prognostic Model and Its Potential Drug Repurposing in Colorectal Cancer Based on TCGA, GTEx and GEO Databases
   Feng Yang et al, 2021, Frontiers in Genetics CrossRef
6. Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo
   Bo Zhou et al, 2019, Journal of Ovarian Research CrossRef
7. Co-regulation and function of FOXM1/RHNO1 bidirectional genes in cancer
   Carter J Barger et al, 2021, eLife CrossRef
8. Structure of the RAD9-RAD1-HUS1 checkpoint clamp bound to RHINO sheds light on the other side of the DNA clamp
   Kodai Hara et al, 2020, Journal of Biological Chemistry CrossRef
9. A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma
   Henrik Gregersen et al, 2018, Experimental Hematology & Oncology CrossRef